WallStreetZenWallStreetZen

NASDAQ: OKUR
Onkure Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their OKUR stock forecasts and price targets.

Forecast return on equity

Is OKUR forecast to generate an efficient return?

Company
-47.54%
Industry
176.76%
Market
256.68%
OKUR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OKUR forecast to generate an efficient return on assets?

Company
-43.35%
Industry
79.01%
OKUR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OKUR earnings per share forecast

What is OKUR's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$3.80
Avg 2 year Forecast
-$3.20
Avg 3 year Forecast
-$2.33

OKUR revenue forecast

What is OKUR's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$680.0k
Avg 2 year Forecast
$1.0M
Avg 3 year Forecast
$1.0M

OKUR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OKUR$2.71N/AN/A
ATNM$1.18N/AN/A
BTAI$1.67$7.00+319.16%Buy
CRVO$3.99$28.00+601.75%Strong Buy
PTN$20.90$60.00+187.08%Strong Buy
View Top Biotech Stocks

Onkure Therapeutics Stock Forecast FAQ

What is OKUR's earnings growth forecast for 2026-2028?

(NASDAQ: OKUR) Onkure Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 73.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 111.66%.

Onkure Therapeutics's earnings in 2026 is -$81,208,000.On average, 6 Wall Street analysts forecast OKUR's earnings for 2026 to be -$51,476,382, with the lowest OKUR earnings forecast at -$63,199,639, and the highest OKUR earnings forecast at -$44,526,156. On average, 5 Wall Street analysts forecast OKUR's earnings for 2027 to be -$43,300,044, with the lowest OKUR earnings forecast at -$59,349,241, and the highest OKUR earnings forecast at -$34,852,742.

In 2028, OKUR is forecast to generate -$31,576,787 in earnings, with the lowest earnings forecast at -$36,645,169 and the highest earnings forecast at -$25,748,352.

If you're new to stock investing, here's how to buy Onkure Therapeutics stock.

What is OKUR's revenue growth forecast for 2026-2028?

(NASDAQ: OKUR) Onkure Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 71.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 60.53%.

Onkure Therapeutics's revenue in 2026 is $0.On average, 6 Wall Street analysts forecast OKUR's revenue for 2026 to be $9,212,816, with the lowest OKUR revenue forecast at $0, and the highest OKUR revenue forecast at $28,451,218. On average, 4 Wall Street analysts forecast OKUR's revenue for 2027 to be $13,819,163, with the lowest OKUR revenue forecast at $0, and the highest OKUR revenue forecast at $28,451,218.

In 2028, OKUR is forecast to generate $13,819,163 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $28,451,218.

What is OKUR's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: OKUR) forecast ROA is -43.35%, which is lower than the forecast US Biotechnology industry average of 79.01%.

What is OKUR's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: OKUR) Onkure Therapeutics's current Earnings Per Share (EPS) is -$13.47. On average, analysts forecast that OKUR's EPS will be -$3.80 for 2026, with the lowest EPS forecast at -$4.66, and the highest EPS forecast at -$3.29. On average, analysts forecast that OKUR's EPS will be -$3.20 for 2027, with the lowest EPS forecast at -$4.38, and the highest EPS forecast at -$2.57. In 2028, OKUR's EPS is forecast to hit -$2.33 (min: -$2.70, max: -$1.90).

What is OKUR's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: OKUR) forecast ROE is -47.54%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.